A Message from the President of Serenity Lane
Leadership News, Treatment Services Added and More: An Update from President Mike Dyer
Spring is here. The flowers are blooming, and the days are getting longer. This is truly a time of growth and renewal. Serenity Lane has a busy summer ahead. In keeping with the spirit of our mission to save lives and put families back together, we continue to innovate and grow to better serve our patients. It is my honor to share these exciting updates with you.
Incoming CEO Pete Kerns will step into his new role June 17th. Earlier this month, he attended Serenity Lane’s annual leadership retreat where his energy and enthusiasm were infectious. In the weeks ahead, he will meet with key staff and begin engaging with our on-going work to update our strategic plan. We look forward to sharing more of this strategic planning process and Pete’s vision for the future later this summer.
Day Treatment Program Arrives
We are now providing Day Treatment (also known as Partial Hospitalization) to patients at our Coburg campus. Day Treatment is the highest level of substance use disorder care after residential treatment. Patients attend programming five to seven days a week for up to six hours a day. Patients have the option to live at home or live on campus for an additional room and board fee.
Day Treatment is a great option for individuals looking for comprehensive treatment that allows them to balance their care with personal and professional life. The programming is currently only offered at our Coburg campus, but we hope to expand this level of care to our outpatient offices in the future.
Expanding Medication-Assisted Treatment and Mental Health Services to Outpatient
We’ll soon be able to prescribe buprenorphine to patients at our outpatient office off West 11th Avenue in Eugene, OR. We will also be adding more mental health services at this location. This expansion of services will help us better engage and treat more patients in the outpatient setting.
Serenity Lane Partners on Major Drug Use Study
Serenity Lane partnered with The Center for Substance Abuse Research (CESAR) at the University of Maryland on a study of drug use patterns in patients seeking substance use disorder treatment. The study revealed high rates of combined opioid and methamphetamine use, marijuana and “polydrug” use. The results were notable enough that CESAR will send a medical anthropologist to meet with Serenity Lane staff and patients later this month to conduct a follow up “HotSpot” analysis.
CEO and President, Serenity Lane